Pfizer Sold Carcinogen-Tainted Chantix, Buyers Claim

By Hailey Konnath · October 8, 2021, 9:28 PM EDT

Pfizer has allegedly been peddling "adulterated, misbranded and unapproved" Chantix, a drug designed to help people quit smoking, consumers said in a proposed class action on Friday, specifically claiming that the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

PLAINTIFF v. DEFENDANT

Case Number

Court

Pennsylvania Western

Nature of Suit

Date Filed

January 03, 2024

Recent Articles By Hailey

June 18, 2024
Novant Pays $6.7M For Sharing Patient Data With Facebook
June 10, 2024
Baltimore Lands $45M Deal With Allergan In Opioid Litigation
June 07, 2024
Motley Rice Allocated Biggest Share Of $2B Opioid Fees
June 04, 2024
Divided 9th Circ. Reverses Sutter Health Antitrust Trial Victory
May 31, 2024
Caremark Cut Loose From CVS Price-Gouging Case
May 13, 2024
'Grinch' Is Not A Protected Class, HHS Tells 4th Circ.
May 03, 2024
Ala. High Court Won't Rethink Decision On Frozen Embryos
May 02, 2024
7th Circ. Mostly Backs Ill. Home Health Kickbacks Judgment
April 30, 2024
Ex-Olympus Exec Says He Was Fired For Flagging FDA Issue
April 26, 2024
HHS Finalizes Bolstered Sexual Orientation Bias Protections